Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94].

Autor: Fitzgerald KN; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lee CH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Voss MH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Carlo MI; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Knezevic A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Peralta L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chen Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lefkowitz RA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shah NJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Owens CN; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., McHugh DJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Aggen DH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Laccetti AL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kotecha RR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Feldman DR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: motzerr@mkscc.org.
Jazyk: angličtina
Zdroj: European urology [Eur Urol] 2025 Jan; Vol. 87 (1), pp. 96. Date of Electronic Publication: 2024 Oct 18.
DOI: 10.1016/j.eururo.2024.10.002
Databáze: MEDLINE
Externí odkaz: